'Bio 9 Ventures', a global boutique firm supporting disruptive Life sciences initiatives that can impact the planet.


To transform healthcare by leveraging new technologies and approaches, making healthcare safer and more effective, efficient, and affordable.

We are currently pivoted as a Cross-border Business Gateway for many Life Sciences Enterprises. Our main purpose is to build global economic health frontiers across America's, Africa and Asia-Pacific regions, collaborate and scale innovative companies that support quality of life, represent high growth opportunity and align with Bio 9's mission of democratizing healthcare globally.

First slide

Venture Partnering

We scale investments through partnerships, planning product rollouts and manage key development transitions such as capitalization or syndication. We do back Health systems often coinvest with like-minded organizations on investments of any size, thereby allowing for diversified risk and a broader customer base for respective portfolio.


We do include a focus on monetizing internal intellectual capital, such as inventions developed by researchers or practitioners or resources developed through investments part of our Financial goals. We create a consensus on how investment and clinical goals are to be aligned.

Social Investments

We do incorporate ethics and social concerns into our portfolio. We do run community support intervention programs that addresses socioeconomic and behavioral barriers to health in low-income populations by providing support for high-risk patients.

Value-based-Care alignment

We recognize the need for solutions that advance value-based care initiatives and support quality-of-care objectives. We constantly empower our clients, vendors, and operations in supporting initiatives that drive physician and consumer engagement, payer-provider partnerships that facilitate risk management, and empower financial success to our portfolio.